Hanmi Pharm Co Ltd

Common Name
Hanmi Pharm
Country
South Korea
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,270
Ticker
128940
Exchange
KOREA EXCHANGE
Description
Hanmi Pharm Co., Ltd. is a prominent pharmaceutical company known for its innovative approach to drug development and manufacturing in South Korea. Its core function centers around researching and pro...

Hanmi Pharm's Climate Target Data Preview

As of 2024, Hanmi Pharm has disclosed 6 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 6 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Hanmi Pharm ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2025
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2026
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2027
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2028
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2029
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Hanmi Pharm's Greenhouse Gas Emissions Pathways

As of 2024, Hanmi Pharm has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does Hanmi Pharm have a target to reduce the emissions from its operations?

As of 2024, Hanmi Pharm has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Hanmi Pharm's most ambitious operational target is to reduce these emissions by 30% by 2030, compared to a baseline of 71,810 Metric Tonnes of CO2 equivalent (mtCO2e) in 2018.

As of 2023, Hanmi Pharm is ahead of schedule on its operational emissions reduction target, having achieved 49.07% of the planned reduction.

Hanmi Pharm's Operational (Scope 1+2) Emissions Pathway

20182023202520262027202820292030020 k40 k60 k80 kBaselineCurrent (-15%)Target 2030 (-30%)
Want Full Access to Hanmi Pharm's Climate Targets Dataset?
Sign Up